Login

RADIENT PHARMACEUTICALS Corp 8-K SEC Filings

Filed On Filing
06 May 2014 8-K: Departure/Election of Directors or Officers; Compensation; Other Events
11 Jun 2013 8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more
17 Jul 2012 8-K: Entry into a Material Definitive Agreement
26 Jun 2012 8-K: Departure/Election of Directors or Officers; Compensation
21 May 2012 8-K: Entry into a Material Definitive Agreement; Other Events
30 Apr 2012 8-K: Other Events
03 Apr 2012 8-K: Triggering Events That Accelerate a Financial Obligation
28 Mar 2012 8-K: Triggering Events That Accelerate a Financial Obligation
26 Mar 2012 8-K: Departure/Election of Directors or Officers; Compensation
07 Mar 2012 8-K: Regulation FD Disclosure; Other Events
01 Mar 2012 8-K: Regulation FD Disclosure
23 Feb 2012 8-K: Triggering Events That Accelerate a Financial Obligation; Notice of Delisting or Failure to Satisfy a Listing Rule +1 more
03 Jan 2012 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Regulation FD Disclosure +1 more
01 Dec 2011 8-K: Unregistered Sales of Equity Securities; Regulation FD Disclosure
29 Nov 2011 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +3 more
15 Nov 2011 8-K: Regulation FD Disclosure; Other Events
07 Nov 2011 8-K: Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure
29 Aug 2011 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
22 Aug 2011 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
15 Aug 2011 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support